LEDIPASVIR & SOFOSBUVIR (NOVISOF-L) TABLET – TREATMENT FOR CHRONIC HEPATITIS C VIRUS (HCV) INFECTION
Novisof L Tablet is an antiviral drug. It is used in conjunction with other drugs to treat chronic hepatitis C virus (HCV) infection. It works by reducing the amount of the hepatitis C virus in the body and gradually eradicating the infection from the blood.
Novisof L Tablet should be taken in the dose and for the length of time prescribed by your doctor. Even if you feel better, do not miss any doses and complete the entire course of treatment. It should be taken with food and preferably at a predetermined time. If you forget to take a dose, do so as soon as possible.
USES OF LEDIPASVIR & SOFOSBUVIR (NOVISOF-L) TABLET
- Chronic hepatitis C virus (HCV) infection
WORKS OF LEDIPASVIR & SOFOSBUVIR (NOVISOF-L) TABLET
Novisof L Tablet is an antiviral drug. It works by reducing the amount of the hepatitis C virus in the body and gradually eradicating the infection from the blood.
SIDE EFFECTS OF ERYTHROPOIETIN (WEPOX) INJECTION
The majority of adverse effects do not necessitate medical treatment and will go away as your body adjusts to the medication. Consult your doctor if they persist or if you are concerned.
- Insomnia (difficulty in sleeping)
- Anemia (low number of red blood cells)
WARNING & PRECAUTIONS
Novisof L Tablet may have adverse effects that impair your ability to drive.
When combined with other drugs for the treatment of hepatitis C infection, Novisof L Tablet may cause dizziness and blurred vision, which may impair your ability to drive.
In patients with severe kidney disease, Novisof L Tablet should be taken with caution. Novisof L Tablet dosage may need to be adjusted. Please consult your physician.
There is little information available on the use of Novisof L Tablet in these individuals. In patients with mild to severe kidney disease, no dose change is indicated.
Novisof L Tablet is safe to use in patients with liver disease. There is no need to change the Novisof L Tablet dosage.
Fedelty Health Care is a Ledipasvir & Sofosbuvir third-party manufacturer, bulk pharma exporter, and pharmaceutical contract manufacturer operating businesses in Venezuela, Saudi Arabia, Cambodia, Oman, Brazil, Lebanon, and Chile, Peru, Cuba, and Fiji. Other services they provide are hospital supply, government supply, named patient supply, cold chain supply, and drop shipping.